EP3303632

F. HOFFMANN-LA ROCHE AG
Application Number
EP16732373A
Filing Date
May 27, 2016
Status
Patent Maintained As Amended
Apr 7, 2023
Grant Date
May 10, 2023
External Links
Slate, Register

Biblio Summary

The patent EP3303632B2 was granted on May 10, 2023 by F. Hoffmann-La Roche Ag The patent is currently Patent Maintained As Amended.

The table below shows 2 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ARES TRADING S.A.Dec 4, 2020ADMISSIBLE
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITEDDec 4, 2020ADMISSIBLE

The table below shows the patents of F. Hoffmann-La Roche Ag that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3257564Overload And Elute ChromatographyMay 29, 20241
EP3294770Therapeutic And Diagnostic Methods For CancerMar 20, 20242
EP3998095Device For Sustained Delivery Of A Therapeutic FluidJan 31, 20241